Limitations of the study of subcutaneous versus oral administration of methotrexate in patients with active rheumatoid arthritis: comment on the article by Braun et al.
Raghu
Padmanabhan
P
Grover
Paramjeet Singh
PS
Kumar
Ashok
A
D000284:Administration, Oral; D018501:Antirheumatic Agents / Q000008:administration & dosage*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D006801:Humans; D007279:Injections, Subcutaneous; D008727:Methotrexate / Q000008:administration & dosage*; D016896:Treatment Outcome
D018501:Antirheumatic Agents; D008727:Methotrexate